This library summarises progesterone-related menopause research in plain language, including uterine protection, sleep, mood, perimenopause, combined hormone therapy and patient safety considerations.
Browse Research Book AssessmentWomen with an intact uterus often need progesterone when systemic estrogen is used.
Progesterone is often discussed in relation to sleep quality and night-time symptoms.
Progesterone changes may occur before estrogen levels become consistently low.
Some women notice mood and anxiety changes during progesterone fluctuations.
Progesterone is often part of combined menopause hormone therapy plans.
Choice of product, dose and schedule should be personalised.
Add a plain-language summary of the study here.
Key Finding: Insert key finding.
Clinical Relevance: Explains why progesterone is commonly required when systemic estrogen is prescribed to women with an intact uterus.
Publication Year: XXXX
Evidence Strength: High / Moderate / Emerging
Insert study summary.
Key Finding: Insert key finding.
Clinical Relevance: Helps explain why sleep is often part of a progesterone discussion.
Insert study summary.
Key Finding: Insert key finding.
Clinical Relevance: Helps explain symptoms that may occur before periods stop completely.
This depends on uterus status, estrogen use and your individual treatment plan.
Some women report improved sleep, but treatment should be individualised.
Schedules vary depending on menopause stage, bleeding pattern and treatment goals.
Side effects vary and should be reviewed during follow-up.
Women with an intact uterus usually should not use systemic estrogen without appropriate endometrial protection.
Regulated prescribed products are often preferred because dosing and quality control are clearer.
Research helps explain the principles, but the right plan depends on symptoms, uterus status, hormone use, risk profile and follow-up.
Book Assessment Learn About HRT